|

American Samoa Dengue Outbreak: What 1,048 Cases and 35% Hospitalized Mean

ByLife Choice Note

Short answer: CDC reported 1,048 laboratory-confirmed dengue cases in American Samoa from June 2025 through August 2026, including 371 hospitalizations (35%). That 35% is not the severe-disease rate among all residents or all infections. The denominator contains reported, symptomatic, laboratory-confirmed cases and likely misses many mild or asymptomatic infections.

Publication date: November 12, 2026 · Location: American Samoa · Surveillance period: June 2025–August 2026 · Population: 1,048 confirmed symptomatic cases · Reviewed: November 14, 2026

What did the outbreak report find?

American Samoa declared a dengue public-health emergency in July 2025. The CDC and territorial health department investigation identified 1,048 confirmed cases during the reporting period, equivalent to 211 cases per 10,000 residents.

  • 814 cases (78%) occurred in people younger than 20.
  • 371 patients (35%) were hospitalized, and no deaths were reported.
  • 999 cases (95%) were classified as locally acquired.
  • Among 146 cases that were serotyped, 136 (93%) were DENV-1 and 10 (7%) were DENV-2.
  • At peak occupancy, dengue patients used 18 of the hospital’s approximately 110 available beds (16%).

Does 35% mean that one in three dengue infections became severe?

No. The outbreak denominator includes people who developed symptoms, were reported and had a positive test. People with no symptoms or mild illness who were never tested are not counted. Admission can also depend on age, local clinical practice, follow-up options, testing access and the capacity of the island’s only hospital.

The result should not be restated as a 35% severe-dengue risk or as a 35% hospitalization risk for travelers.

Why were 78% of confirmed cases under age 20?

The report describes the age pattern but does not establish its cause. Previous exposure and immunity, where mosquito exposure occurred, school and household conditions, and differences in testing or care-seeking could all contribute. Incidence was highest among children aged 10–14, but the investigation did not prove that a particular behavior or personal characteristic caused the pattern.

Why did on-island testing matter?

This was American Samoa’s first dengue outbreak with local confirmatory testing. In earlier outbreaks, specimens had to be shipped to Hawaii. On-island NS1 antigen and RT-PCR testing allowed the first cases to be confirmed within days. Ninety-nine percent of all confirmed cases were identified with NS1 or RT-PCR.

The response included clinician training, hospital surge planning, community cleanup, residual insecticide spraying and spatial emanators. Because this was an outbreak investigation without a comparison group, it cannot quantify how much any one intervention caused the later decline.

Can these results be applied to other countries or travelers?

Not directly. American Samoa is a tropical territory that CDC classifies as having frequent or continuous dengue risk. The report does not estimate locally acquired dengue risk in South Korea, the United States as a whole or for every traveler. Its surveillance period also ended in August 2026, so the totals are not a real-time case count for November 14.

WHO notes that many dengue infections are asymptomatic or mild, while a smaller proportion become severe. Travelers should use current destination-specific public-health information, and anyone who becomes ill after travel should tell a clinician where and when they traveled.

Important limitations

  • Laboratory-confirmed symptomatic surveillance does not capture all infections.
  • Only 146 of 1,048 cases were serotyped.
  • The 35% hospitalization figure cannot be transferred to settings with different admission practices and access to care.
  • The observational outbreak report cannot compare the independent effects of response measures.
  • Events after August 2026 are not included.

Primary sources

Written by: Life Choice Note, independent personal health-information explainer · Reviewed: November 14, 2026

This article explains surveillance data from one location. It does not diagnose an individual infection, predict personal severity or direct treatment.

Related guides